{
  "_metadata": {
    "description": "Manually pinned items that always appear at the top of the news ticker. Edit this file to add/remove pinned items.",
    "last_updated": "2026-02-10"
  },
  "pinned": [
    {
      "headline": "Eli Lilly acquires Orna Therapeutics for up to $2.4B — in vivo CAR-T for autoimmune",
      "source": "Manual",
      "url": "",
      "published": "2026-02-09",
      "category": "deal",
      "tickers": ["LLY"],
      "importance": 5,
      "one_liner": "Lilly acquires Orna for $2.4B — in vivo CAR-T for autoimmune diseases"
    },
    {
      "headline": "Kymera BREADTH Phase 2b in asthma — first patient dosed",
      "source": "Manual",
      "url": "",
      "published": "2026-01-29",
      "category": "clinical_data",
      "tickers": ["KYMR"],
      "importance": 5,
      "one_liner": "KYMR: BREADTH Phase 2b first patient dosed in asthma (STAT6 degrader)"
    },
    {
      "headline": "Formation Bio licenses miR-124 activator from CTFH for up to $500M — new subsidiary Kenmare Bio",
      "source": "Manual",
      "url": "",
      "published": "2026-01-29",
      "category": "deal",
      "tickers": [],
      "importance": 4,
      "one_liner": "Formation Bio enters miR-124 space — licenses FHND5032 for up to $500M"
    }
  ]
}
